-
The National Drug Supervision and Administration Work Conference was held in Beijing
Time of Update: 2023-02-02
On January 5, the National Drug Supervision and Administration Work Conference was held in Beijing. The meeting was guided by Xi Jinping Thought on Socialism with Chinese Characteristics for a New Er
-
The National Health Insurance Administration responded that Pfizer's new crown treatment drugs were not included in medical insurance
Time of Update: 2023-02-01
In response to Pfizer's failure to enter the medical insurance catalog through medical insurance negotiations, Huang Xinyu, deputy director of the Department of Pharmaceutical Service Management of the National Medical Insurance Administration, said in Beijing on the 11th that although Paxlovid failed to negotiate successfully this time, according to the current new crown drug reimbursement policy, Paxlovid can still be temporarily reimbursed until March 31, 2023.
-
Shenzhen supports enterprises to expand the production capacity of rescue medical devices and drugs
Time of Update: 2023-02-01
The measure proposes that Shenzhen will include enterprises undertaking the production tasks of extracorporeal membrane oxygenation machines, ventilators, oxygen generators, nasal high-flow humidification therapy instruments, gamma globulin and other production tasks into the white list for key support, and make every effort to coordinate and ensure the continuous production of whitelisted enterprises and their core supplier enterprises.
-
Yunnan has carried out a special campaign to stabilize the price and quality of epidemic-related drugs and medical supplies
Time of Update: 2023-02-01
The reporter learned from the Yunnan Provincial Market Supervision Administration on the 11th that market supervision departments at all levels in Yunnan Province will carry out a 6-month special act
-
The State Council Joint Prevention and Control Mechanism Press Conference Authoritative Response!
Time of Update: 2023-02-01
The monitoring of the new coronavirus in the sewage of residential buildings can better play the role of monitoring and early warning of residential buildings, Hong Kong through community sewage monitoring, timely detection of areas where there may be infected people, and then further tracking and finding positive infections, and then taking corresponding control measures, mainly applied in the early stage of the epidemic when there was no large-scale epidemic.
-
What is the development prospect of China's pharmaceutical equipment industry in 2023? Industry: will usher in an upward cycle
Time of Update: 2023-02-01
From the perspective of the development environment of the pharmaceutical equipment industry, in terms of policy environment, with the continuous improvement of the medical system reform and social security mechanism, the policy is continuing to support and encourage the high-quality development of the domestic pharmaceutical equipment industry, especially the high-end pharmaceutical equipment industry.
-
China's exports of industrial products increased by nearly 10%! The international market has become an important market for the layout of pharmaceutical machine enterprises
Time of Update: 2023-02-01
Pharmaceutical machine industry (Image source: Pharmaceutical Network) The international market has become an important market for the layout of pharmaceutical machine enterprises Canaan Technology said on the investor interactive platform on January 9 that the international market is an important market for the company's business, and the company will pay close attention to relevant policy notices and market dynamics.
-
In the key year of the "14th Five-Year Plan", how do pharmaceutical equipment companies do?
Time of Update: 2023-02-01
(Image source: Pharma Network) Innovative development Under the background of the aging of the population, the gradual enhancement of residents' health awareness and the continuous upgrading of consumption levels, the consumption demand for pharmaceutical products and services will continue to increase, driving the market scale of the upstream pharmaceutical equipment industry to expand.
-
The eighth batch of large-scale variety games: Pfizer, Sanofi, AstraZeneca, Coron, Yangtze River, etc. compete for the 60 billion market!
Time of Update: 2023-02-01
Among the multinational original research enterprises, Pfizer, Sanofi, Merck, Lundbeck, AstraZeneca, Eisai and other enterprises are listed, of which Pfizer has the largest number of products, and 3 varieties are to be included, with cefoperazone sulbactam injection and voriconazole injection having a high market share.
-
Jiao Hong investigates the quality and supply of new crown epidemic prevention and control drugs in Hebei
Time of Update: 2023-02-01
, Jiao Hong and his entourage inspected the work of epidemic prevention and control drug supply guarantee, storage and transportation, and investigated the implementation of quality management standards for drug business and strengthening quality management in circulation links 。 Jiao Hong pointed out that at present, China's epidemic prevention and control has entered a new stage, and the people have higher requirements for the quality safety and supply guarantee of new coronavirus infection treatment drugs.
-
The clinical mass spectrometry track has attracted a large influx of capital, and the enthusiasm for financing in 2022 is high
Time of Update: 2023-02-01
js?cdnversion='+~(-new Date()/36e5)]; Keyword: The clinical mass spectrometry track has attracted a large influx of capital, and the enthusiasm for financing in 2022 is high, clinical mass spectrometry Next:Traditional Chinese medicine accelerates its development in the direction of modernization, and the help of the pharmaceutical machine industry is needed Previous:The founding CEO of CStone Pharmaceuticals joins traditional pharmaceutical companies, is Biotech not fragrant?
-
The PDC track is hot! Domestic and foreign pharmaceutical companies are competing for layout
Time of Update: 2023-02-01
Specifically, on December 22, 2022, Merck and PeptiDream entered into an agreement to discover and develop new PDCs based on PeptiDream's drug discovery and development platform technology PDPS (Peptide Discovery Platform System), and PeptiDream will receive an upfront payment and may receive a total of up to $2.
-
The FDA approved a new drug for Alzheimer's disease, which can slow cognitive decline, but the side effects are controversial
Time of Update: 2023-02-01
Aducanumab was immediately controversial after it was approved by the FDA, with clinical trials showing that the monoclonal antibody could clear β-amyloid (Aβ) from the brain, but there was not enough evidence to slow or stop the progression of Alzheimer's disease 。 In addition, there was a risk of side effects, with 425 patients (41.
-
In 2023, the API industry will continue to be news, related to the approval of varieties, production, and export...
Time of Update: 2023-02-01
Fengyuan Pharmaceutical said on the investor interactive platform on January 13 that the company's paracetamol API actively expands its export business while meeting the needs of the domestic market.
-
Development status of China's medical device industry in 2022
Time of Update: 2023-02-01
(The author of this article is the director of the Southern Institute of Pharmaceutical Economics of the State Medical Products Administration) In the past three years, under the influence of the new crown epidemic, the number of medical device manufacturers in China has grown rapidly, exceeding 30,000 in 2022, reaching 31,503 as of September 2022.
-
Since the implementation of the "Category B and B Management" policy, the number of people entering and leaving the country has recovered in an orderly manner
Time of Update: 2023-02-01
The average daily number of arrivals and exits at seaports, land routes and air ports was 21,000, 424,000 and 45,000 respectively, an increase of 13%, 53.
The average daily number of arrivals and exits at seaports, land routes and air ports was 21,000, 424,000 and 45,000 respectively, an increase of 13%, 53.
-
Another batch of pharmaceutical companies announced fundraising projects, mainly focusing on new drug research and development and other fields
Time of Update: 2023-02-01
279 billion yuan after the IPO of Xintong Drug Science and Technology Innovation Board, of which 900 million yuan will be used for new drug research and development projects, 180 million yuan will be used for innovative drug industrialization production base construction projects, and 200 million yuan will be used for supplementary working capital projects.
-
There are long-term development opportunities in the traditional Chinese medicine sector, and there are huge investment opportunities in these three segments in 2023
Time of Update: 2023-02-01
Planting and primary processing of Chinese medicinal materials Recently, the State Food and Drug Administration issued Several Measures on Further Strengthening the Scientific Supervision of Chinese Medicines and Promoting the Inheritance, Innovation and Development of Chinese Medicines, which mentioned that the supervision and inspection of Chinese medicine tablets, Chinese medicine formula granules and proprietary Chinese medicines should be continuously strengthened, and the extended inspection of Chinese medicinal materials should be carried out in an orderly manner.
-
In the past week, a large number of pharmaceutical companies have obtained drug registration certificates!
Time of Update: 2023-02-01
News on January 13, Huaren Pharmaceutical said that it recently received the "Drug Registration Certificate" of "sodium bicarbonate Ringer injection" approved and issued by the National Medical Products Administration.
-
In the past 10 days, 8 pharmaceutical and biological companies such as Zhifei Biotechnology have been investigated by overseas institutions
Time of Update: 2023-02-01
js?cdnversion='+~(-new Date()/36e5)];According to industry statistics, in the past 10 days (January 3 to January 16), overseas institutions conducted research on 64 listed companies, which are mainly concentrated in household appliances, machinery and equipment, electronics, medicine and biology and other industries, including 8 pharmaceutical and biological companies.
